In mouse models of experimental arthritis and DSS (dextran sulphate sodium)-induced colitis, PTPN22 deficiency resulted in increased intestinal susceptibility to inflammatory agents and pronounced disease progression, indicating that PTPN22 is required to protect individuals from systemic and gastrointestinal inflammation. Here, PTPN22 is linked to arthritic joint disease.